Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies

• Angela C. Weyand,
• Veronica H. Flood,
• Jordan A. Shavit,
• Steven W. Pipe

Affiliations

Angela C. Weyand

Division of Hematology and Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, MI;; Angela C. Weyand, University of Michigan, 1150 W Medical Center Dr, MSRB III, Room 8220, Ann Arbor, MI 48109

Veronica H. Flood

Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI;; Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI;; Division of Hematology and Oncology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI

Jordan A. Shavit

Division of Hematology and Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, MI;

Steven W. Pipe

Division of Hematology and Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, MI;; Department of Pathology, University of Michigan, Ann Arbor, MI